そうだったんだ!　脂肪酸

出版社： 文光堂
著者：
発行日： 2013-03-27
分野： 臨床医学：内科  >  循環器一般
ISBN： 9784830619199
電子書籍版： 2013-02-26 （第1版第4刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

8,800 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

8,800 円(税込)

購入する

商品紹介

PUFAあるいは脂肪酸といってもピンとこない方のために，本書は，PUFAに関する知識の乏しい初心者向けに，その作用機序から最近のエビデンスに至るまで，その分野のエキスパートが，わかりやすく記述することにより，医療従事者のPUFAに対する理解を深めることを目的とした。

目次

  • そうだったんだ！　脂肪酸

    ―目次―

    ［1］beyond LDL，なぜ今脂肪酸？
    　　1．beyond LDL，なぜ今脂肪酸？
    ［2］脂肪酸をわかりやすく説明しましょう
    　　1．脂肪酸の種類を説明しましょう
    　　2．脂肪酸の主な働き
    　　3．必須多価不飽和脂肪酸とはどのようなものか
    ［3］脂肪酸からみた循環器疾患の疫学
    　　1．魚を食べると心筋梗塞が減る？─疫学的根拠─
    　　2．脂肪酸のバランスが崩れてきている現代人
    　　　One Point Advice　知ってほしいトランス脂肪酸のリスク
    　　　One Point Advice　EPA/AAとは何？その正常値は？
    ［4］脂肪酸の持つ薬理学的効果
    　　1．血小板凝集を抑制します
    　　　Controversy　抗血小板療法にはアスピリンそれともEPA？
    　　2．脂質異常症を是正します─n-3系多価不飽和脂肪酸の効果─
    　　3．降圧効果が認められます
    　　4．血管機能を改善する効果があります
    　　　One Point Advice　
    　　　　多価不飽和脂肪酸は血液レオロジーを改善する
    　　5．血管の弾性を改善します─動脈スティフネスと脂肪酸─
    　　6．動脈硬化を抑制する効果があります
    　　　One Point Advice　今注目されている中鎖脂肪酸とは
    　　7．組織の炎症を抑制します
    　　8．不整脈を抑制する効果があります
    ［5］脂肪酸の循環器疾患予防効果
    　　1．冠動脈疾患を予防します
    　　　Controversy　どの指標が最適？─EPA濃度，EPA/AA比または
    　　　　　　　　　　　Omega-3 index─
    　　2．心臓突然死や心房細動を減らすかもしれない
    　　3．心不全を予防し，心機能を改善するかもしれない
    　　4．脳血管疾患を予防します
    　　5．末梢動脈疾患の症状と予後の改善に貢献する
    　　6．慢性腎臓病の血管を守ります
    　　7．高リスク患者の一次予防に有効です
    ［6］脂肪酸の知識を循環器診療に活かす
    　　1．どのようにEPA，DHA摂取を指導したらよいか
    　　　One Point Advice
    　　　　α-リノレン酸を摂取するとEPA，DHAが増加するか？
    　　　One Point Advice　魚の調理法と多価不飽和脂肪酸バランス
    　　2．どのような症例にEPA製剤で治療介入すべきか？
    　　　Controversy　治療効果はEPA投与量，血中濃度の
    　　　　　　　　　　どちらに依存するか？
    ［7］注目されている脂肪酸のトピックス
    　　1．糖尿病に効くかもしれない
    　　2．自律神経に良い影響を与えるらしい
    　　3．慢性炎症を積極的に抑制するらしい
    　　4．血管新生抑制作用─加齢黄斑変性モデルでの検討─
    　　5．抗うつ効果があるかもしれない
    　　　One Point Advice　
    　　　　多価不飽和脂肪酸は認知症を抑制するらしい

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

P.9 掲載の参考文献
1) Alagona,P,Jr:Beyond LDL cholesterol:the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.Am J Manag Care 2009;15(3Suppl):S65-S73
 
2) 日本動脈硬化学会:動脈硬化性疾患予防ガイドライン2012年版, 日本動脈硬化学会, 2012
 
3) 水産庁:平成22年度水産の動向第1部第2章第1節(1)水産物の消費動向,平成22年度水産白書,http://www.jfa.maff.go.jp/j/kikaku/wpaper/h22_h/trend/1/t1_2_1_1.html
 
4) Rosamond,W et al:Heart disease and stroke statistics-2008 update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.Circulation 2008;117:e25-e146
 
5) 厚生統計協会:国民衛生の動向,厚生の指標 1989;36:48
 
6) de Lorgeril,M et al:Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.Lancet 1994;343:1454-1459
 
7) Scandinavian Simvastatin Survival Study Group:Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study(4S).Lancet 1994;344:1383-1389
 
8) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients(JELIS):a randomised open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
9) Saito,Y et al:Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors:sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study(JELIS).Atherosclerosis2008;200:135-140
 
10) Yanagisawa,N et al:Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area.J Atheroscler Thromb 2010;17:285-294
 
P.21 掲載の参考文献
1) 上代淑人ほか(監訳):イラストレイテッドハーパー・生化学,原書28版,丸善,東京, 479-499,2011
 
2) Simons,K et al:Functional rafts in cell membranes.Nature 1997;387:569-572
 
3) Simons,K et al:Lipid rafts and signal transduction.Nat Rev Mol Cell Biol 2000;1:31-39
 
4) 山科郁男ほか(監修):レーニンジャーの新生化学,第5版,廣川書店,東京, 501-537,941-973,2010
 
P.31 掲載の参考文献
1) 文部科学省:五訂増補日本食品標準成分表脂肪酸成分表, 2005
 
2) 厚生労働省:日本人の食事摂取基準2010年版, 2009
 
3) 北畠顕ほか:虚血性心疾患の一次予防ガイドライン(2006年改訂版),循環器病の診断と治療に関するガイドライン(2005年度合同研究班報告).http://www.j-circ.or.jp/guideline/pdf/JCS2006_kitabatake_h.pdf
 
P.38 掲載の参考文献
1) Worth,RM et al:Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan,Hawaii and California:mortality.Am J Epidemiol 1975;102:481-490
 
2) Ueshima,H:Explanation for the Japanese paradox:prevention of increase in coronary heart disease and reduction in stroke.J Atheroscler Thromb 2007;14:278-286
 
3) Keys,A(Ed):Coronary heart disease in seven countries.Circulation 1970;41(4 Suppl):1-211
 
4) Dyerberg,J et al:A hypothesis on the development of acute myocardial infarction in Greenlanders.Scand J Clin Lab Invest Suppl 1982;161:7-13
 
5) Iso,H et al:Serum fatty acids and fish intake in rural Japanese,urban Japanese,Japanese American and Caucasian American men.Int J Epidemiol 1989;18:374-381
 
6) Kromhout,D et al:The inverse relation between fish consumption and 20-year mortality from coronary heart disease.N Engl J Med 1985;312:1205-1209
 
7) Mozaffarian,D et al:Fish intake,contaminants,and human health:Evaluating the risks and the benefits.JAMA 2006;296:1885-1899
 
8) Yuan,JM et al:Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai,China.Am J Epidemiol 2001;154:809-816
 
9) Nakamura,Y et al:Association between fi sh consumption and all-cause and cause-specifi c mortality in Japan NIPPON DATA80,1980-99.Am J Med 2005;118:239-245
 
10) Yamagishi,K et al:Fish,w-3 polyunsaturated fatty acids,and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese:the JACC(Japan Collaborative Cohort Study for Evaluation of Cancer Risk)Study.J Am Coll Cardiol 2008;52:988-996
 
11) Iso,H et al:Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese.The Japan Public Center-Based(JPHC) Study Cohort I.Circulation 2006;113:195-202
 
12) 佐藤眞一ほか:心筋梗塞発症への血清中脂肪酸の寄与に関する集団内症例対照研究.J Epidemiol 1999;9(Suppl):47
 
13) Marchioli,R et al:Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction:Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico(GISSI)-Prevenzione.Circulation 2002;105:1897-1903
 
14) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolemic patients(JELIS):a randomised open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
15) Wang,C et al:n-3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies:a systematic review.Am J Clin Nutr 2006;84:5-17
 
16) Kitamura,A et al:Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan,1964 to 2003:The Akita-Osaka Study.J Am Coll Cardiol 2008;52:71-79
 
17) 水産庁:平成23年度水産白書.http://www.jfa.maff.go.jp/j/kikaku/wpaper/h23/index.html
 
P.45 掲載の参考文献
1) Tapiero,H et al:Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed Pharmacother 2002;56:215-222
 
2) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients(JELIS):a randomised open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
3) Donadio,JV,Jr et al:A randomized trial of highdose compared with low-dose omega-3 fatty acids in severe IgA nephropathy.J Am Soc Nephrol 2001;12:791-799
 
4) Grimm,H et al:Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients.Eur J Nutr 2006;45:55-60
 
5) Rosenzweig,T et al:Post-operative deepvein thrombosis is infrequent in Alaska Natives.Int J Circumpolar Health 2003;62:388-396
 
6) Dyerberg,J et al:A hypothesis on the development of acute myocardial infarction in Greenlanders.Scand J Clin Lab Invest Suppl 1982;161:7-13
 
P.47 掲載の参考文献
1) Zock,PL et al:Dietary trans-fatty acid and serum lipoproteins in humans.Curr Opin Lipidol 1996;7:34-37
 
2) Mozaffarian,D et al:Trans fatty acids and cardiovascular disease.N Engl J Med 2006;354:1601-1613
 
3) Oomen,CM et al:Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study:a prospective population based study.Lancet 2001;357:746-751
 
4) Willett,WC et al:Intake of trans fatty acids and risk of coronary heart disease among women.Lancet 1993;341:581-585
 
P.55 掲載の参考文献
1) Nomura,S et al:Function and role of microparticles in various clinical settings.Thromb Res 2008;123:8-23
 
2) Dyerberg,J et al:Eicosapentaenoic acid prevention of thrombosis and atherosclerosis.Lancet 1978;2:117-119
 
3) 寺野隆ほか:EPA-抗動脈硬化,抗血栓作用-.治療学 1995;29:1197-1201
 
4) Nomura,S et al:High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells.Atherosclerosis 2001;158:277-287
 
5) Nomura,S et al:Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan.J Atheroscler Thromb 2009;16:878-887
 
6) Hatmi,M et al:Interference of eicosapentaenoic and docosahexaenoic acids with arachidonate-and U46619-induced platelet activation and desensitization.Biochem Pharmacol 1988;37:481-489
 
7) Swann,PG et al:Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets.FEBC Lett 1989;243:244-246
 
8) Scheurlen,M et al:Fish oil preparations rich in docosahexaenoic acid modify platelet responsiveness to prostaglandin-endoperoxide/thromboxane A2 receptor agonists.Biochem Pharmacol 1993;46:245-249
 
9) Nomura,S et al:Correlation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabetes mellitus.Thromb Res 2008;122:39-45
 
10) Nomura,S et al:The effects of pitavastatin,eicosapentaenoic acid and combined therapy on plateletderived microparticles and adiponectin in hyperlipidemic,diabetic patients.Platelets 2009;20:16-22
PubMed
11) Nomura,S et al:Effects of eicosapentaenoic acid on endothelial cell-derived microparticles,angiopoietins and adiponectin in patients with type 2 diabetes.J Atheroscler Thromb 2009;16:83-90
 
P.57 掲載の参考文献
1) Antithrombotic trialists' collaboration:Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ 2002;324:71-86
 
2) Dyerberg,J et al:Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978;2:117-119
 
3) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients(JELIS):a randomised open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
4) Pearson,TA et al:AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke:2002 Update:Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases.American Heart Association Science Advisory and Coordinating Committee.Circulation 2002;106:388-391
PubMed
5) Saito,Y et al:Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors:sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study(JELIS).Atherosclerosis 2008;200:135-140
 
P.63 掲載の参考文献
1) Steinberg,D:Thematic review series:the pathogenesis of atherosclerosis.An interpretive history of the cholesterol controversy:part II:the early evidence linking hypercholesterolemia to coronary disease in humans.J Lipid Res 2005;46:179-190
 
2) Keys,A:Coronary heart disease in seven countries.1970.Nutrition 1997;13:250-252
 
3) Kris-Etherton,PM et al:Individual fatty acid effects on plasma lipids and lipoproteins:human studies.Am J Clin Nutr 1997;65:1628S-1644S
 
4) Keys,A et al:Serum cholesterol response to changes in dietary lipids.Am J Clin Nutr 1966;19:175-181
 
5) Hegsted,DM et al:Quantitative effects of dietary fat on serum cholesterol in man.Am J Clin Nutr 1965;17:281-295
 
6) Kromhout,D et al:Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease:The Seven Countries Study.Prev Med 1995;24:308-315
 
7) Zock,PL et al:Dietary trans-fatty acids and serum lipoproteins in humans.Curr Opin Lipidol 1996;7:34-37
 
8) Dyerberg,J et al:Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978;2:117-119
 
9) Bang,HO et al:The composition of the Eskimo food in north western Greenland.Am J Clin Nutr 1980;33:2657-2661
 
10) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients(JELIS):a randomised open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
11) Harris,WS:n-3 Fatty acids and health:DaVinci's Code.Am J Clin Nutr 2008;88:595-596
 
12) Bays,A:Clinical overview of Omacor:a concentrated formulation of omega-3 polyunsaturated fatty acids.Am J Cardiol 2006;98(4A):71i-76i
 
13) Mozaffarian,D et al:Omega-3 fatty acids and cardiovascular disease.J Am Coll Cardiol 2011;58:2047-2067
 
14) Harris,WS:n-3 Fatty acids and serum lipoproteins:human studies.Am J Clin Nutr 1997;65:1645S-1654S
 
15) Stalenhoef,AF et al:The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins,low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.Atherosclerosis 2000;153:129-138
 
16) Harris,WS et al:Safety and efficacy of Omacor in severe hypertriglyceridemia.J Cardiovasc Risk 1997;4:385-391
 
17) Durrington,PN et al:An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia.Heart 2001;85:544-548
 
18) Itakura,H et al:The change in low-density lipoprotein cholesterol concentration is positively related to plasma docosahexaenoic acid but not eicosapentaenoic acid.J Atheroscler Thromb 2012;19:673-679
PubMed
19) Harris,WS et al:Omega-3 fatty acids and coronary heart disease risk:clinical and mechanistic perspectives.Atherosclerosis 2008;197:12-24
 
20) Bernstein,AM et al:A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease.J Nutr 2012;142:99-104
 
21) Hersher,R:Are drugmakers fishing for a market with prescription omega-3s? Nat Med 2012;18:6
PubMed
22) Miller,M et al:Incorporation of oleic acid and eicosapentaenoic acid into glycerolipids of cultured normal human fibroblasts.Lipids 1993;28:1-5
PubMed
23) Fisher,EA et al:The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways.J Biol Chem 2001;276:27855-27863
 
24) Jump,DB:The biochemistry of n-3 polyunsaturated fatty acids.J Biol Chem 2002;277:8755-8758
 
25) Yoshikawa,T et al:Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor(LXR) binding to LXR response elements.J Biol Chem 2002;277:1705-1711
 
26) Zhao,A et al:Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets.DNA Cell Biol 2004;23:519-526
 
27) Khan,S et al:Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype.J Lipid Res 2002;43:970-985
 
28) Davidson,M:Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids.Am J Cardiol 2006;98(4A):27i-33i
 
29) Tanaka,K et al:Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients:subanalysis of the JELIS trial.Stroke 2008;39:2052-2058
 
30) Saito,Y et al:Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors:sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study(JELIS).Atherosclerosis 2008;200:135-140
 
P.66 掲載の参考文献
1) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolemic patients(JELIS):a randomized open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
2) Ueshima,H et al:Food omega-3 fatty acid intake of individuals(total,linolenic acid,long-chain) and their blood pressure:INTERMAP study.Hypertension 2007;50:313-319
 
3) Morris,MC et al:Does fish oil lower blood pressure? A meta-analysis of controlled trial.Circulation 1993;88:523-533
 
4) Geleijnse,JM et al:Blood pressure response to fi sh oil supplementation:metaregression analysis of randomized trial.J Hypertens 2002;20;1493-1499
 
5) Dokholyon,RS et al:A trial of omega-3 fatty acids for prevention of hypertension.Am J Cardiol 2004;93:1041-1043
 
6) Miyajima,T et al:Effects of eicosapentaenoic acid on blood pressure,cell membrane fatty acids,and intracellular sodium concentration in essential hypertension.Hypertens Res 2001;24:537-542
 
7) Mozaffarian,D et al:Fish intake,contaminants,and human health.Evaluating the risk and benefi ts.JAMA 2006;296:1885-1899
 
8) Mozaffarian,D:Fish,n-3 fatty acids,and cardiovascular haemodynamics.J Cardiovasc Med 2007;8:S23-S26
 
9) Oh,DY et al:GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin sensitizing eff ects.Cell 2010;142:687-698
 
P.70 掲載の参考文献
1) Mohler,ER,3rd:Therapy insight:peripheral arterial disease and diabetes--from pathogenesis to treatment guidelines.Nat Clin Pract Cardiovasc Med 2007;4:151-162
 
2) Abeywardena,MY et al:Longchain n-3 polyunsaturated fatty acids and blood vessel function.Cardiovasc Res 2001;52:361-371
 
3) Green,DJ et al:Flow-mediated dilation and cardiovascular event prediction:does nitric oxide matter? Hypertension 2011;57:363-369
 
4) Wang,Q et al:Effect of omega-3 fatty acids supplementation on endothelial function:a meta-analysis of randomized controlled trials.Atherosclerosis 2012;221:536-543
 
5) Chen,J et al:Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts.Circulation 2011;123:584-593
 
6) Chisaki,K et al:Eicosapentaenoic acid suppresses basal and insulin-stimulated endothelin-1 production in human endothelial cells.Hypertens Res 2003;26:655-661
 
7) Yamada,H et al:In Vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid.Arterioscler Thromb Vasc Biol 2008;28:2173-2179
 
P.71 掲載の参考文献
1) 栗原毅ほか:血液レオロジー測定装置MC-FANの臨床応用の試み.日ヘモレオロジー会誌 2001;4:43-52
 
2) Kurihara,T et al:Effects of eicosapentaenoic acid on blood rheology in hyperlipidemic fatty liver patients.Hemorheol and Related Res 1999;2:1-8
 
3) Kurihara,T et al:Impaired blood rheology by remnant-like lipoprotein particles:studies in patients with fatty liver disease.Clin Hemorheol Microcirc 2001;24:217-225
 
P.75 掲載の参考文献
1) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients(JELIS):a randomised open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
2) Vrabl ik,M et al:Omega-3 fatty acids and cardiovascular disease risk:do we understand the relationship? Res 2009;58 Suppl 1:S19-S26
 
3) Tomiyama,H et al:Non-invasive vascular function tests:their pathophysiological background and clinical application.Circ J 2010;74:24-33
PubMed
4) Pase,MP et al:The effects of dietary and nutrient interventions on arterial stiffness:a systematic review.Am J Clin Nutr 2011;93:446-454
 
5) Siasos,G et al:Effects of omega-3 fatty acids on endothelial function,arterial wall properties,inflammatory and fibrinolytic status in smokers:a cross over study.Int J Cardiol 2011 Nov 17
 
6) Tomiyama,H et al:Do EPA attenuate age-related increases in arterial stiffness in patients with dyslipidemia.Hypertens Res 2005;28:651-655
 
7) Mita,T et al:Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes.Atherosclerosis 2007;191:162-167
 
8) Domei,T et al:Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention.Circ J 2012;76:423-429
 
9) Tomiyama,H et al:Relationships among the serum omega fatty acid levels,serum C-reactive protein levels and arterial stiffness/wave reflection in Japanese men.Atherosclerosis 2011;217:433-436
 
P.81 掲載の参考文献
1) Albert,CM et al:Blood levels of long-chain n-3 fatty acids and the risk of sudden death.N Engl J Med 2002;346:1113-1118
 
2) Daviglus,ML et al:Fish consumption and the 30-year risk of fatal myocardial infarction.N Engl J Med 1997;336:1046-1053
 
3) Dolecek,TA:Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial.Proc Soc Exp Biol Med 1992;200:177-182
 
4) Erkkila,AT et al:n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease.Am J Clin Nutr 2003;78:65-71
 
5) Burr,ML et al:Effects of changes in fat,fish,and fibre intakes on death and myocardial reinfarction:diet and reinfarction trial(DART).Lancet 1989;2:757-761
 
6) GISSI-Prevenzione Investigators:Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction:results of the GISSI-Prevenzione trial.Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto miocardico.Lancet 1999;354:447-455
 
7) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients(JELIS):a randomised open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
8) De Caterina,R et al:Control of endothelial leukocyte adhesion molecules by fatty acids.Lipids 1996;31 Suppl:S57-S63
 
9) De Caterina,R et al:Fatty acid modulation of endothelial activation.Am J Clin Nutr 2000;71:213S-223S
 
10) Terano,T et al:Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals.Lipids 1996;31 Suppl:S301-S304
 
11) Michaud,SE et al:Direct regulatory effect of fatty acids on macrophage lipoprotein lipase:potential role of PPARs.Diabetes 2001;50:660-666
 
12) Mishra,A et al:Oxidized omega-3 fatty acids inhibit NF-B activation via a PPAR-dependent pathway.Arterioscler Thromb Vasc Biol 2004;24:1621-1627
 
13) Thies,F et al:Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques:a randomised controlled trial.Lancet 2003;361:477-485
 
14) Stary,HC et al:A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis:a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis,American Heart Association.Circulation 1995;92:1355-1374
 
15) Amano,T et al:Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability:an integrated backscatter intravascular ultrasound study.Atherosclerosis 2011;218:110-116
PubMed
16) Matsumoto,M et al:Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in apoE-deficient mice.Atherosclerosis 2008;197:524-533
 
17) Kris-Etherton,PM et al:Fish consumption,fish oil,omega-3 fatty acids,and cardiovascular disease.Circulation 2002;106:2747-2757
 
18) Saravanan,P et al:Cardiovascular effects of marine omega-3 fatty acids.Lancet 2010;376:540-550
 
19) Calder,PC:The role of marine omega-3(n-3) fatty acids in inflammatory processes,atherosclerosis and plaque stability.Mol Nutr Food Res 2012;56:1073-1080
 
20) Serhan,CN:Resolution phase of inflammation:novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.Annu Rev Immunol 2007;25:101-137
 
P.83 掲載の参考文献
1) Hirano,K et al:A novel clinical entity:triglyceride deposit cardiomyovasculopathy.J Atheroscler Thromb 2009;16:702-705
 
2) Scheig,R et al:Hepatic metabolism of 1-14C octanoic and 1-14C palmitic acids.J Am Oil Chem Soc 1968;45:31-33
 
3) Kasai,M et al:Effect of dietary medium-and long-chain triacylglycerols(MLCT) on accumulation of body fat in healthy humans.Asia Pac J Clin Nutr 2003;12:151-160
 
4) 野坂直久ほか:タンパク・エネルギー低栄養(PEM)のリスクを保有する高齢者における中鎖脂肪酸摂取が血清アルブミン値に及ぼす影響.日臨栄会誌 2010;32:52-61
 
5) Hirano,K et al:Triglyceride deposit cardiomyovasculopathy.N Engl J Med 2008;359:2396-2398
 
P.90 掲載の参考文献
1) Bang,HO et al:Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos.Lancet 1971;1:1143-1145
 
2) GISSI-Prevenzione Investigators:Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction:results of the GISSI-Prevenzione trial.Lancet 1999;354:447-455
 
3) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patient(JELIS):a randomized openlabel,blinded endopoint analysis.Lancet 2007;369:1090-1098
 
4) Duda,MK et al:Fish oil,but not flaxseed oil,decreases inflammation and prevents pressure overload-induced cardiac dysfunction.Cardiovasc Res 2009;81:319-327
 
5) Lopez-Garcia,E et al:Consumption of(n-3) fatty acids is related to plasma biomarkers of infl ammation and endothelial activation in women.J Nutr 2004;134:1806-1811
 
6) Kang,JX et al:Transgenic mice:fat-1 mice convert n-6 to n-3 fatty acids.Nature 2004;427:504
 
7) Kang,JX et al:Fat-1 transgenic mice:a new model for omega-3 research.Prostaglandins Leukot Essent Fatty Acids 2007;77:263-267
 
8) Wan, JB et al:Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-defi cient mice by inhibiting systemic and vascular inflammation.Arterioscler Thromb Vasc Biol 2010;30:2487-2494
 
9) White,PJ et al:Transgenic restoration of longchain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesitylinked inflammation and insulin resistance in high-fat-fed mice.Diabetes 2010;59:3066-3073
 
10) Schwab,JM et al:Resolvin E1 and protectin D1 activate inflammation-resolution programmes.Nature 2007;447:869-874
 
11) Claria,J et al:Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.Proc Natl Acad Sci USA 1995;92:9475-9479
 
12) Serhan,CN et al:Resolving inflammation:dual anti-inflammatory and pro-resolution lipid mediators.Nat Rev Immunol 2008;8:349-361
 
13) Keyes,KT et al:Resolvin E1 protects the rat heart against reperfusion injury.Am J Physiol Heart Circ Physiol 2010;299:153-164
 
14) Arita,M:Mediator lipidomics in acute inflammation and resolution.J Biochem 2012;152:313-319
 
P.95 掲載の参考文献
1) London,B et al:Omega-3 fatty acids and cardiac arrhythmias:prior studies and recommendations for future research:a report from the National Heart,Lung,and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop.Circulation 2007;116:e320-e335
 
2) Mozaffarian,D et al:Omega-3 fatty acids and cardiovascular disease:effects on risk factors,molecular pathways,and clinical events.J Am Coll Cardiol 2011;58:2047-2067
 
3) Wu,JHY et al:Association of plasma phospholipid long-chain omega-3 fatty acids with incident atrial fibrillation in older adults:The Cardiovascular Health Study.Circulation 2012;125:1084-1093
 
4) Saravanan,P et al:Cardiovascular effects of marine omega-3 fatty acids.Lancet 2010;376:540-550
 
5) Marik,PE et al:Omega-3 dietary supplements and the risk of cardiovascular events:a systematic review.Clin Cardiol 2009;32:365-372
 
6) Lavie,CJ et al:Omega-3 polyunsaturated fatty acids and cardiovascular diseases.J Am Coll Cardiol 2009;54:585-594
 
7) Nodari,S et al:n-3 Polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion:a prospective,randomized study.Circulation 2011;124:1100-1106
 
8) Kumar,S et al:Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion.Heart Rhythm 2012;9:483-491
 
P.102 掲載の参考文献
1) Kromhout,D et al:Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease:the Seven Countries Study.Prev Med 1995;24:308-315
 
2) Libby,P:Current concepts of the pathogenesis of the acute coronary syndromes.Circulation 2001;104:365-372
 
3) Weber,C et al:The multifaceted contributions of leukocyte subsets to atherosclerosis:lessons from mouse models.Nat Rev Immunol 2008;8:802-815
 
4) Dyerberg,J et al:Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978;2:117-119
 
5) Albert,CM et al:Fish consumption and risk of sudden cardiac death.JAMA 1998;279:23-28
 
6) Dolecek,TA et al:Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial(MRFIT).World Rev Nutr Diet 1991;66:205-216
 
7) Iso,H et al:Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese:the Japan Public Health Center-Based(JPHC)Study Cohort I.Circulation 2006;113:195-202
 
8) Burr,ML et al:Effects of changes in fat,fish,and fibre intakes on death and myocardial reinfarction:diet and reinfarction trial(DART).Lancet 1989;2:757-761
 
9) GISSI-Prevenzione Investigators:Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction:results of the GISSI-Prevenzione trial.Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.Lancet 1999;354:447-455
 
10) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients(JELIS):a randomised open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
11) Saito,Y et al:Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors:sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study(JELIS).Atherosclerosis 2008;200:135-140
 
12) Matsuzaki,M et al:Incremental effects of eicosapentaenoic acid on cardiovascular events in statintreated patients with coronary artery disease.Circ J 2009;73:1283-1290
 
13) Studer,M et al:Effect of different antilipidemic agents and diets on mortality:a systematic review.Arch Intern Med 2005;165:725-730
 
14) Yanagisawa,N et al:Polyunsaturated fatty acid levels of serum and red blood cells in apparenqatly healthy Japanese subjects living in an urban area.J Atheroscler Tromb 2010;17:285-294
 
15) 島田和典:EPA/AA比は食習慣を反映する心血管疾患の新たなリスクマーカーか? 心臓 2011;43:354-355
 
P.105 掲載の参考文献
1) Mozaffarian,D et al:Omega-3 fatty acids and cardiovascular disease:effects on risk factors,molecular pathways,and clinical events.J Am Coll Cardiol 2011;58:2047-2067
 
2) Harris,WS:Omega-3 fatty acids and cardiovascular disease:a case for omega-3 index as a new risk factor.Pharmacol Res 2007;55:217-223
 
3) Yanagisawa,N et al:Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area.J Atheroscler Thromb 2010;17:285-294
 
P.110 掲載の参考文献
1) Mozaffarian,D et al:Fish intake and risk of incident atrial fibrillation.Circulation 2004;110:368-373
 
2) Virtanen,JK et al:Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men.Circulation 2009;120:2315-2321
 
3) Calo,L et al:n-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery:a randomized,controlled trial.J Am Coll Cardiol 2005;45:1723-1728
 
4) Heidt,MC et al:Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery:a prospective randomized study.Thorac Cardiovasc Surg 2009;57:276-280
 
5) Kumar,S et al:Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion.Heart Rhythm 2012;9:483-491
 
6) Brouwer,IA et al:Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation.The Rotterdam Study.Am Heart J 2006;151:857-862
 
7) Frost,L et al:n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter:the Danish Diet,Cancer,and Health Study.Am J Clin Nutr 2005;81:50-54
 
8) Saravanan,P et al:Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery:a randomized,double-blind,placebo-controlled clinical trial.Circ Arrhythm Electrophysiol 2010;3:46-53
 
9) GISS-Prevenzione Investigators:Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction:results of the GISSI-Prevenzione trial.Lancet 1999;354:447-455
 
10) Siscovick,DS:Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest.JAMA 1995;274:1363-1367
 
11) Albert,CM:Blood levels of long-chain n-3 fatty acids and the risk of sudden death.N Engl J Med 2002;346:1113-1118
 
12) Nodari,S et al:The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy.Cardiovasc Drugs Ther 2009;23:5-15
 
13) GISS-HF Investigators:Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure(the GISSI-HF trial):a randomised,doubleblind,placebo-controlled trial.Lancet 2008;372:1223-1230
 
14) Saravanan,P et al:Cardiovascular effects of marine omega-3 fatty acids.Lancet 2010;376:540-550
 
P.114 掲載の参考文献
1) De Caterina,R:n-3 Fatty acids in cardiovascular disease.N Engl J Med 2011;364:2439-2450
 
2) Yamagishi,K et al:Fish,omega-3 polyunsaturated fatty acids,and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC(Japan Collaborative Cohort Study for Evaluation of Cancer Risk)Study.J Am Coll Cardiol 2008;52:988-996
 
3) Giugliano,D et al:The effects of diet on inflammation:emphasis on the metabolic syndrome.J Am Coll Cardiol 2006;48:677-685
 
4) Joshipura,KJ et al:The effect of fruit and vegetable intake on risk for coronary heart disease.Ann Intern Med 2001;134:1106-1114
 
5) Jensen,MK et al:Intakes of whole grains,bran,and germ and the risk of coronary heart disease in men.Am J Clin Nutr 2004;80:1492-1499
 
6) de Lorgeril,M et al:Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.Lancet 1994;343:1454-1459
 
7) de Lorgeril,M et al:Mediterranean diet,traditional risk factors,and the rate of cardiovascular complications after myocardial infarction:final report of the Lyon Diet Heart Study.Circulation 1999;99:779-785
 
8) Singh,RB et al:Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients(Indo-Mediterranean Diet Heart Study):a randomised single-blind trial.Lancet 2002;360:1455-1461
 
9) Lichtenstein,AH et al:Diet and lifestyle recommendations revision 2006:a scientific statement from the American Heart Association Nutrition Committee.Circulation 2006;114:82-96
 
10) Djousse,L et al:Relation between modifiable lifestyle factors and lifetime risk of heart failure.JAMA 2009;302:394-400
 
11) 厚生労働省:日本人の食事摂取基準(2010年版)http://www.mhlw.go.jp/bunya/kenkou/sessyu-kijun.html
 
12) Mozaffarian,D et al:Fish intake and risk of incident heart failure.J Am Coll Cardiol 2005;45:2015-2021
 
13) Belin,RJ et al:Fish intake and the risk of incident heart failure:the Women's Health Initiative.Circ Heart Fail 2011;4:404-413
 
14) Tavazzi,L et al:Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure(the GISSI-HF trial):a randomised,double-blind,placebo-controlled trial.Lancet 2008;372:1223-1230
 
15) Nodari,S et al:Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy.J Am Coll Cardiol 2011;57:870-879
 
16) Kenchaiah,S et al:Obesity and the risk of heart failure.N Engl J Med 2002;347:305-313
 
17) Lavie,CJ et al:Obesity and cardiovascular disease:risk factor,paradox,and impact of weight loss.J Am Coll Cardiol 2009;53:1925-1932
 
18) Evans,WJ et al:Cachexia:a new definition.Clin Nutr 2008;27:793-799
 
19) Wigmore,SJ et al:The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer.Nutrition 1996;12:S27-S30
 
20) Barber,MD et al:The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.Br J Cancer 1999;81:80-86
 
21) Freeman,LM et al:Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure.J Vet Intern Med 1998;12:440-448
 
22) Mehra,MR et al:Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure.J Heart Lung Transplant 2006;25:834-838
 
P.119 掲載の参考文献
1) 脳卒中合同ガイドライン委員会:脳卒中治療ガイドライン2009.協和企画, 東京, 2009
 
2) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients(JELIS):a randomised open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
3) Tanaka,K et al:Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients:subanalysis of the JELIS trial.Stroke 2008;39:2052-2058
 
4) Amarenco,P et al:High-dose atorvastatin after stroke or transient ischemic attack.N Engl J Med 2006;355:549-559
 
5) Nakamura,H et al:Primary prevention of cardiovascular disease with pravastatin in Japan(MEGA Study):a prospective randomised controlled trial.Lancet 2006;368:1155-1163
 
6) 田中耕太郎ほか:高コレステロール血症患者の脳卒中発症に対するEPAの効果-JELISサブ解析結果.脳卒中 2007;29:762-766
 
7) Tanaka,K et al:Relationship of ischemic stroke with serum lipid levels,and influence of plasma eicosapentaenoic acid(EPA) concentration in patients with hypercholesterolemia.The 6th World Stroke Congress,Vienna,Austria,September 26, 2008
 
P.123 掲載の参考文献
1) Criqui,MH et al:Mortality over a period of 10 years in patients with peripheral arterial disease.N Engl J Med 1992;326:381-386
 
2) Fujiwara,T et al:Prevalence of asymptomatic arteriosclerosis obliterans and its relationship with risk factors in inhabitants of rural communities in Japan:Tanno-Sobetsu study.Atherosclerosis 2004;177:83-88
 
3) Cacoub,PP et al:Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health(REACH) Registry.Atherosclerosis 2009;204:e86-e92
 
4) Carrero,JJ et al:Daily supplementation with(n-3)PUFAs,oleic acid,folic acid,and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease.J Nutr 2005;135:1393-1399
 
5) Madden,J et al:Fish oil induced increase in walking distance,but not ankle brachial pressure index,in peripheral arterial disease is dependent on both body mass index and inflammatory genotype.Prostaglandins Leukot Essent Fatty Acids 2007;76:331-340
PubMed
6) 柏木厚典:磁気共鳴法を用いた糖尿病性足病変に対する新しい早期診断法.Ther Res 2004;25:323-328
 
7) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients(JELIS):a randomised open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
8) Ishikawa,Y et al:Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease.Circ J 2010;74:1451-1457
 
9) 堀正二ほか:循環器疾患における抗凝固・抗血小板療法に関するガイドライン(2009年改訂版),循環器病の診断と治療に関するガイドライン(2008年度合同研究班報告).http://www.j-circ.or.jp/guideline/pdf/JCS2009_hori_h.pdf
 
P.126 掲載の参考文献
1) Rasmussen,LE et al:The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease.Nutr Res 2010;30:535-540
 
2) Friedman,AN et al:Fish consumption and omega-3 fatty acid status and determinants in longterm hemodialysis.Am J Kidney Dis 2006;47:1064-1071
 
3) Nakamura,N et al:Serum lipid profile and plasma fatty acid composition in hemodialysis patients-comparison with chronic kidney disease patients.In Vivo 2008;22:609-611
 
4) Madsen,T et al:Marine n-3 polyunsaturated fatty acids in patients with end-stage renal failure and in subjects without kidney disease:a comparative study.J Ren Nutr 2011;21:169-175
 
5) Hamazaki,K et al:The relationship between n-3 long-chain polyunsaturated fatty acids and pulse wave velocity in diabetic and non-diabetic patients under long-term hemodialysis.A horizontal study.Clin Nephrol 2009;71:508-513
 
6) Hamazaki,K et al:Docosahexaenoic acid is an independent predictor of all-cause mortality in hemodialysis patients.Am J Nephrol 2011;33:105-110
 
7) Ando,M et al:Eicosapentaenoic acid reduces plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients.J Am Soc Nephrol 1999;10:2177-2184
 
8) Svensson,M et al:The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis:a randomized placebo-controlled intervention study.Nephrol Dial Transplant 2008;23:2918-2924
 
9) Kooshki,A et al:Effects of omega-3 fatty acids on serum lipids,lipoprotein(a), and hematologic factors in hemodialysis patients.Ren Fail 2011;33:892-898
 
10) Svensson,M et al:N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis:a randomized,placebo-controlled intervention trial.Clin J Am Soc Nephrol 2006;1:780-786
 
11) Svensson,M et al:The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis.J Ren Nutr 2007;17:243-249
 
12) Kirkegaard,E et al:Marine n-3 fatty acids,atrial fibrillation and QT interval in haemodialysis patients.Br J Nutr 2012;107:903-909
 
13) Lok,CE et al:Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts:a randomized controlled trial.JAMA 2012;307:1809-1816
 
P.130 掲載の参考文献
1) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients(JELIS):a randomised open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
2) The Long-Term Intervention with Pravastatin in Ischaemic Disease(LIPID) Study Group:Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.N Engl J Med 1998;339:1349-1357
 
3) Shepherd,J et al:Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia.West of Scotland Coronary Prevention Study Group.N Engl J Med 1995;333:1301-1307
 
4) Saito,Y et al:Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors:sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study(JELIS).Atherosclerosis 2008;200:135-140
 
5) 日本動脈硬化学会編:動脈硬化性疾患予防ガイドライン2012年版,日本動脈硬化学会, 2012
 
6) Fuller,JH et al:Coronary-heart-disease risk and impaired glucose tolerance.The Whitehall study.Lancet 1980;1:1373-1376
 
7) Tominaga,M et al:Impaired glucose tolerance is a risk factor for cardiovascular disease,but not impaired fasting glucose.The Funagata Diabetes Study.Diabetes Care 1999;22:920-924
 
8) Oikawa,S et al:Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism:Subanalysis of the Japan EPA Lipid Intervention Study(JELIS).Atherosclerosis 2009;206:535-539
 
9) Oikawa,S et al:Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy:implication from Japan Lipid Intervention Trial(J-LIT).Atherosclerosis 2007;191:440-446
 
10) Mita,T et al:Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes.Atherosclerosis 2007;191:162-167
 
P.134 掲載の参考文献
1) Iso,H et al:Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese:The Japan Public Health Center-Based(JPHC)Study Cohort I.Circulation 2006;113:195-202
 
2) 厚生労働省「日本人の食事摂取基準」策定検討会:日本人の食事摂取基準[2010年版],第一出版,東京, 2009
 
3) Brouwer,IA et al:Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease,but increased prostate cancer risk:a meta-analysis.J Nutr 2004;134:919-922
 
P.136 掲載の参考文献
1) Brenna,JT et al:alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans.Prostaglandins Leukot Essent Fatty Acids 2009;80:85-91
 
2) Kawabata,T et al:Associations between dietary n-6 and n-3 fatty acids and arachidonic acid compositions in plasma and erythrocytes in young and elderly Japanese volunteers. Lipids Health Dis 2011;10:138-143
 
P.137 掲載の参考文献
1) 渡邊智子:日本食品標準成分表の策定及び活用に関する研究.栄養誌 2011;69:214-228
 
2) 久保加織:魚脂質の加工・調理による変化.New Food Industry 2002;44:23-29
 
3) 浅川具美:加熱調理における青魚の脂質の変化.日本調理科学会誌 1997;30:301-305
 
P.144 掲載の参考文献
1) Yokoyama,M et al:Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients(JELIS):a randomised open-label,blinded endpoint analysis.Lancet 2007;369:1090-1098
 
2) Saito,Y et al:Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors:sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study(JELIS).Atherosclerosis 2008;200:135-140
 
3) Matsuzaki,M et al:Incremental effects of eicosapentaenoic acid on cardiovascular events in statintreated patients with coronary artery disease.Circ J 2009;73:1283-1290
 
4) Oikawa,S et al:Suppressive effects of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism:Subanalysis of the Japan EPA Lipid Intervention Study(JELIS).Atherosclerosis 2009;206:535-539
 
5) He,K et al:Accumulated evidence on fish consumption and coronary heart disease mortality:a meta-analysis of cohort studies.Circulation 2004;109:2705-2711
 
6) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction:results of the GISSI-Prevenzione trial.Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.Lancet 1999;354:447-455
 
7) Gissi-HF Investigators,Tavazzi,L et al:Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure(the GISSI-HF trial):a randomised,double-blind,placebo-controlled trial.Lancet 2008;372:1223-1230
 
8) Studer,M et al:Effect of different antilipidemic agents and diets on mortality:a systematic review.Arch Intern Med 2005;165:725-730
 
9) 堀正二ほか:循環器疾患における抗凝固・抗血小板療法に関するガイドライン(2009年改訂版),循環器病の診断と治療に関するガイドライン(2008年度合同研究班報告).http://www.jcirc.or.jp/guideline/pdf/JCS2009_hori_h.pdf
 
10) 小川久雄ほか:心筋梗塞二次予防に関するガイドライン(2011年改訂版),循環器病の診断と治療に関するガイドライン(2010年度合同研究班報告).http://www.j-circ.or.jp/guideline/pdf/JCS2011_ogawah_h.pdf
 
11) 日本動脈硬化学会編:動脈硬化性疾患予防ガイドライン2012年版, 日本動脈硬化学会, 2012
 
12) 脳卒中合同ガイドライン委員会編:脳卒中治療ガイドライン2009, 協和企画, 2010
 
13) Itakura,H et al:Relationships between plasma fatty acid composition and coronary artery disease.J Atheroscler Thromb 2011;18:99-107
 
P.145 掲載の参考文献
1) Lavie,CJ et al:Omega-3 polyunsaturated fatty acids and cardiovascular diseases.J Am Coll Cardiol 2009;54:585-594
 
2) Mozaffarian,D et al:Omega-3 fatty acids and cardiovascular disease.Effects on risk factors,molecular pathways,and clinical events.J Am Coll Cardiol 2011;58:2047-2067
 
3) Metcalf,RG et al:Effects of fish-oil supplementation on myocardial fatty acids in humans.Am J Clin Nutr 2007;85:1222-1228
 
4) Harris,WS et al:Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease.Am J Cardiol 2006;98:19i-26i
 
P.152 掲載の参考文献
1) 平澤明ほか:消化管脂肪酸受容体とその生理作用YAKUGAKU ZASSI 2011;131;1683-1689
 
2) Civelli,O:GPCR deorphanizations:the novel,the known and the unexpected transmitters.Trends Pharmacol Sci 2005;26:15-19
 
3) Salehi,A et al:Free fatty acid receptor 1(FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion.Cell Tissue Res 2005;322:207-215
 
4) Katsuma,S et al:Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1.J Biol Chem 2005;280:19507-19515
 
5) Oh,DY et al:GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.Cell 2010;142:687-698
 
6) Miyauchi,S et al:Distribution and regulation of protein expression of the free fatty acid receptor GPR120.Naunyn Schmiedebergs Arch Pharmacol 2009;379:427-434
 
7) Holst,JJ et al:Glucagon-like peptide-1,glucose homeostasis and diabetes.Trends Mol Med 2008;14:161-168
 
8) Ichimura,A et al:Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human.Nature 2012;483:350-354
 
P.156 掲載の参考文献
1) Leaf,A et al:Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake.Circulation 2005;112:2762-2768
 
2) Ouellet,M et al:Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier:An in situ cerebral perfusion study.Neurochem Int 2009;55:476-482
 
3) Peet,M et al:Omega-3 fatty acids in the treatment of psychiatric disorders.Drugs 2005;65:1051-1059
 
4) Eto,K et al:Modulation of ATP-induced inward currents by docosahexaenoic acid and other fatty acids in rat nodose ganglion neurons.J Pharmacol Sci 2006;102:343-346
 
5) 伴野祥一ほか:糖尿病性神経障害に対するEPA-E(エパデール(R))の臨床効果.薬理と治療 1992;20:3395-3399
 
6) Martin,DSD et al:Apoptotic changes in the aged brain are triggered by interleukin-1B-induced activation of p38 and reversed by treatment with eicosapentaenoic acid.J Biol Chem 2002;277:34239-34246
 
7) 柳澤厚生ほか:脂肪酸と自律神経:視点を変えて職を考える. 杏林医会誌 2004;35:375-378
 
8) Hamazaki,T et al:Effect of docosahexaenoic acid on hostility.World Rev Nutr Diet 2001;88:47-52
 
9) Dallongeville,J et al:Fish consumption is associated with lower heart rates.Circulation 2003;108:820-825
 
10) Harbaugh,MP et al:Long-chain, n-3 fatty acids and physical activity-Independent and interactive associations with cardiac autonomic control.Int J Cardiol 2012,doi:10.1016/j.ijcard.2012.05.110
 
11) Valera,B et al:Influence of n-3 fatty acids on cardiac autonomic activity among Nunavik Inuit adults.Int J Circumpolar Health 2011;70:6-18
 
12) Mozaffarian,D et al:Dietary fish and w-3 fatty acid consumption and heart rate variability in US adults.Circulation 2008;117:1130-1137
 
13) Abuissa,H et al:Autonomic function, omega-3, and cardiovascular risk.Chest 2005;127:1088-1091
 
14) Nishimura,M et al:Eicosapentaenoic acid stimulates nitric oxide production and decreases cardiac noradrenaline in diabetic rats.Clin Exp Pharmacol Physiol 2000;27:618-624
 
15) Billman,GE:Effect of dietary omega-3 polyunsaturated fatty acids on heart rate and heart rate variability in animals susceptible or resistant to ventricular fibrillation.Front Physiol 2012;3:71
PubMed
16) Christensen,JH et al:n-3 fatty acids and the risk of sudden cardiac death.Lipids 2001;36 Suppl:S115-S118
 
17) Mozaffarian,D et al:Effect of fish oil on heart rate in humans:a meta-analysis of randomized controlled trials.Circulation 2005;112:1945-1952
 
P.162 掲載の参考文献
1) Hotamisligil,GS:Inflammation and metabolic disorders.Nature 2006;444:860-867
 
2) Suganami,T et al:Adipose tissue macrophages:their role in adipose tissue remodeling.J Leuko Biol 2010;88:33-39
 
3) Suganami,T et al:Role of the Toll-like receptor 4/NF-kB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages.Arterioscler Thromb Vasc Biol 2007;27:84-91
 
4) Medzhitov,R:Origin and physiological roles of inflammation.Nature 2008;454:428-435
 
5) Suganami,T et al:Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a toll-like receptor 4 mutation.Biochem Biophys Res Commun 2007;354:45-49
 
6) Bjorkbacka,H et al:Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways.Nat Med 2004;10:416-421
 
7) Itoh,M et al:Adipose tissue remodeling as homeostatic inflammation.Int J Inflam 2011;2011:720926
PubMed
8) Suganami,T et al:A paracrine loop between adipocytes and macrophages aggravates inflammatory changes:role of free fatty acids and tumor necrosis factor a.Arterioscler Thromb Vasc Biol 2005;25:2062-2068
 
9) Itoh,M et al:Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects.Arterioscler Thromb Visc Biol 2007;27:1918-1925
 
10) Yamada,H et al:In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid.Arterioscler Thromb Vasc Biol 2008;28:2173-2179
 
11) Schwab,JM et al:Resolvin E1 and protectin D1 activate inflammation-resolution programmes.Nature 2007;447:869-874
 
12) Lumeng,CN et al:Obesity induces a phenotypic switch in adipose tissue macrophage polarization.J Clin Invest 2007;117:175-184
 
13) Satoh-Asahara,N et al:Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia.Diabetes Care 2012;35:2631-2639
PubMed
P.166 掲載の参考文献
1) Seddon,JM et al:Cigarette smoking,fish consumption,omega-3 fatty acid intake,and associations with age-related macular degeneration:the US Twin Study of Age-Related Macular Degeneration.Arch Ophthalmol 2006;124:995-1001
 
2) Koto,T et al:Eicosapentaenoic Acid is anti-inflammatory in preventing choroidal neovascularization in mice.Invest Ophthalmol Vis Sci 2007;48:4328-4334
 
3) Rodriguez,A et al:Delta6-and delta5-desaturase activities in the human fetal liver:kinetic aspects.J Lipid Res 1998;39:1825-1832
 
P.171 掲載の参考文献
1) WHO:World Health Statistics 2010,2010/09/06
 
2) 日本生物学的精神医学会うつ病対策ワーキンググループ:うつ病対策の総合的提言.日生物精医会誌 2010;21:155-177
 
3) Geddes,JR et al:SSRIs versus other antidepressants for depressive disorder.Cochrane Database Syst Rev 2000;(2):CD001851
PubMed
4) Anderson,IM:Selective serotonin reuptake inhibitors versus tricyclic antidepressants:a meta-analysis of efficacy and tolerability.J Affect Disord 2000;58:19-36
 
5) Hibbeln,JR:Fish consumption and major depression.Lancet 1998;351:1213
PubMed
6) Lin,PY:A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression.Biol Psychiatry 2010;68:140-147
 
7) Bloch,MH et al:Response to critiques on‘Omega-3 fatty acids for the treatment of depression:systematic review and meta-analysis'.Mol Psychiatry 2012 Aug 7.doi:10.1038/mp.2012.116
 
8) Lin,PY et al:Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis,supplement preparation,and severity of depression.Mol Psychiatry 2012 Jul 24.doi:10.1038/mp.2012.111
 
9) Martins,JG et al:Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder:a critique of Bloch and Hannestad and updated meta-analysis.Mol Psychiatry 2012 Apr 10.doi:10.1038/mp.2012.25
 
10) Bloch,MH et al:Omega-3 fatty acids for the treatment of depression:systematic review and meta-analysis.Mol Psychiatry 2011 Sep 20.doi:10.1038/mp.2011.100
 
11) Carney,RM et al:Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease:a randomized controlled trial.JAMA 2009;302:1651-1657
 
12) Bot,M et al:Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus:a randomized,double-blind placebo-controlled study.J Affect Disord 2010;126:282-286
 
13) Ikemoto,A et al:Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus.Neurosci Lett 2000;285:99-102
 
14) Yehuda,S:Fatty acids and brain peptides.Peptides 1998;19:407-419
 
P.172 掲載の参考文献
1) Samieri,C et al:Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk.Am J Clin Nutr 2008;88:714-721
 
2) 大塚美恵子:痴呆患者の食事因子の解析及びエイコサペンタエン酸(EPA)による認知機能改善効果の検討.Dementia Jpn 2001;15:21-29
 

書評

最近チェックした商品履歴

Loading...